<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="017980-2018"
            EDITION="2018010">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-018212-001</RECEPTION_ID>
      <DELETION_DATE>20180422</DELETION_DATE>
      <FORM_LG_LIST>FR </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>10</NO_OJ>
         <DATE_PUB>20180116</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 010-017980</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:017980-2018:TEXT:FR:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>FR</LG_ORIG>
         <ISO_COUNTRY VALUE="FR"/>
         <IA_URL_GENERAL>https://www.chu-rennes.fr</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33621100">Antithrombotic agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="FRH03">Ille-et-Vilaine</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="FRH03">Ille-et-Vilaine</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="FR107">Val-de-Marne</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR103">Yvelines</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">856500</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 143-293988</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180112</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Фpaнция</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Антибиотици</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Francie</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombotika</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Frankrig</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombotiske midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Frankreich</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antithrombotische Mittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γαλλία</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Αντιθρομβωτικά</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antithrombotic agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombóticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Prantsusmaa</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Tromboosivastased ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Ranska</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitromboottiset lääkeaineet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antithrombotiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Fhrainc, an</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antithrombotic agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Francuska</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombotici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Franciaország</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombotikus szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Agenti antitrombotici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Prancūzija</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitromboziniai vaistai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Līdzekļi pret trombozi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Franza</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Aġenti antitrombotiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Frankrijk</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antithrombogene middelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Francja</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Środki obniżające krzepliwość krwi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>França</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombóticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Franţa</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombotice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Francúzsko</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombotické činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antitrombotiki</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Frankrike</TI_CY>
            <TI_TOWN>Rennes</TI_TOWN>
            <TI_TEXT>
               <P>Antikoagulantia</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="FR">Ctre hospitalier Univers Pontchaillou</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="FR">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Ctre hospitalier Univers Pontchaillou</OFFICIALNAME>
               <ADDRESS>rue Henri le Guilloux</ADDRESS>
               <TOWN>Rennes Cedex 9</TOWN>
               <POSTAL_CODE>35033</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <CONTACT_POINT>Service des achats du pôle pharmacie à l'attention de Mme Lagane</CONTACT_POINT>
               <PHONE>+33 299289401</PHONE>
               <E_MAIL>tiphaine.lagane@chu-rennes.fr</E_MAIL>
               <FAX>+33 299283761</FAX>
               <n2016:NUTS CODE="FRH03"/>
               <URL_GENERAL>https://www.chu-rennes.fr</URL_GENERAL>
               <URL_BUYER>http://www.marches-publics.gouv.fr</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE_OTHER>Établissement public de santé</CA_TYPE_OTHER>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Fourniture d'héparine de bas poids moléculaire</P>
            </TITLE>
            <REFERENCE_NUMBER>VGTL1704</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33621100"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Fourniture d'héparine de bas poids moléculaire.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">856500</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>HBPM antithrombotique à visée préventive en chirurgie et en médecine</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33621100"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRH03"/>
               <SHORT_DESCR>
                  <P>Les fournitures pouvant être commandées sont décrites au CCTP et à son annexe nº 1: catalogue des besoins. Les quantités estimatives sont indiquées au catalogue des besoins.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>valeur technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>service rendu par le fournisseur</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>valeur économique</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>HBPM antithrombotique à visée curative en chirurgie et en médecine</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33621100"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRH03"/>
               <SHORT_DESCR>
                  <P>Les fournitures pouvant être commandées sont décrites au CCTP et à son annexe nº 1: catalogue des besoins. Les quantités estimatives sont indiquées au catalogue des besoins.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>valeur technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>service rendu par le fournisseur</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>valeur économique</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>HBPM antithrombotique en cancérologie</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33621100"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRH03"/>
               <SHORT_DESCR>
                  <P>Les fournitures pouvant être commandées sont décrites au CCTP et à son annexe nº 1: catalogue des besoins. Les quantités estimatives sont indiquées au catalogue des besoins.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>valeur technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>service rendu par le fournisseur</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>valeur économique</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 143-293988</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>170968</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>HBPM antithrombotique à visée préventive en chirurgie et en médecine</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi Aventis France</OFFICIALNAME>
                     <ADDRESS>82 avenue Raspail</ADDRESS>
                     <TOWN>Gentilly</TOWN>
                     <POSTAL_CODE>94250</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR107"/>
                     <URL>http://www.sanofi.fr</URL>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">507000</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>170968</CONTRACT_NO>
            <LOT_NO>2</LOT_NO>
            <TITLE>
               <P>HBPM antithrombotique à visée curative en chirurgie et en médecine</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi Aventis France</OFFICIALNAME>
                     <ADDRESS>82 avenue Raspail</ADDRESS>
                     <TOWN>Gentilly</TOWN>
                     <POSTAL_CODE>94250</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR107"/>
                     <URL>http://www.sanofi.fr</URL>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">313500</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>170967</CONTRACT_NO>
            <LOT_NO>3</LOT_NO>
            <TITLE>
               <P>HBPM antithrombotique en cancérologie</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-11-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>LEO Pharma</OFFICIALNAME>
                     <ADDRESS>2 rue René Caudron</ADDRESS>
                     <TOWN>Voisins-le-Bretonneux</TOWN>
                     <POSTAL_CODE>78960</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR103"/>
                     <URL>http://www.leo-pharma.fr</URL>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">36000</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Greffe du tribunal administratif de Rennes</OFFICIALNAME>
               <ADDRESS>3 contour de la Motte</ADDRESS>
               <TOWN>Rennes Cedex</TOWN>
               <POSTAL_CODE>35044</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 223212828</PHONE>
               <FAX>+33 299635684</FAX>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_MEDIATION_BODY>
               <OFFICIALNAME>Comité consultatif interrégional pour le règlement amiable des litiges relatifs aux marchés publics</OFFICIALNAME>
               <ADDRESS>6 quai Ceineray</ADDRESS>
               <TOWN>Nantes</TOWN>
               <POSTAL_CODE>44000</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 240086432</PHONE>
               <FAX>+33 240479068</FAX>
            </ADDRESS_MEDIATION_BODY>
            <REVIEW_PROCEDURE>
               <P>Possibilité d'introduire un référé précontractuel dans les conditions fixées à l'article L. 551.1 du code de justice administrative.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-01-12</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
